Fecal microbiota transplantation in gastrointestinal disorders: time for precision medicine
Nicolas Benech, Harry Sokol
Abstract
Fecal microbiota transplantation (FMT) has demonstrated efficacy in treating inflammatory bowel diseases and irritable bowel syndrome in an increasing number of randomized controlled trials. Recently published data gives striking insights into the factors associated with FMT success paving the road for the use of precision medicine in gastrointestinal disorders.
Topics & Concepts
Irritable bowel syndromeFecal bacteriotherapyMedicineRandomized controlled trialFecesTransplantationInternal medicineGastroenterologyIntensive care medicineBiologyAntibioticsMicrobiologyClostridium difficileClostridium difficile and Clostridium perfringens researchGastrointestinal motility and disordersHelicobacter pylori-related gastroenterology studies